Freis, E.D.: Hypertension: Office Evaluation. New York, American Heart Association, 1972, p. 18.
2.
Jagger, P.I., Braunwald, E.: Hypertensive vascular disease, in Harrison's Principles of Internal Medicine. Eighth edition. Edited by G. W. Thorn.New York, McGraw-Hill , 1977, p. 1307.
3.
Dustan, H.P. : Evaluation and therapy of hypertension. Mod. Concepts Cardiovasc. Dis., 45: 97-103, 1976.
4.
Page, L.B., Yager, H.M., Sidd, J.J.: Drugs in the management of hypertension. Part I. Am. Heart J., 91: 810-815, 1976.
Page, L.B., Yager, H.M., Sidd, J.J.: Drugs in the management of hypertension. Part II. Am. Heart J., 92: 114-118, 1976.
7.
Gifford, R.W., Jr.: A practical guide to medical management, in The Hypertension Handbook, Chapter 5. West Point, PA: Merck, Sharp & Dohme, 1974, pp. 91-96.
8.
Frohlich, E.D. : Inhibition of adrenergic function in the treatment of hypertension. Arch. Intern. Med., 133: 1033-1044, 1974.
9.
Drayer, J.I.M. , Keim, H.J., Weber , M.A., et al.: Unexpected pressor responses to propranolol in essential hypertension: An interaction between renin, aldosterone and sympathetic activity. Am. J. Med., 60: 897-903, 1976.
10.
Page, L.B., Yager, H.M., Sidd, J.J.: Drugs in the management of hypertension. Part III. Am. Heart J., 92: 252-259, 1976.
11.
Koch-Weser, J.: Vasodilator drugs in the treatment of hypertension . Arch. Intern. Med., 133: 1017-1024, 1974 .
Stokes, G.S. , Oates, H.F.: Prazosin: New alpha-adrenergic blocking agent in treatment of hypertension. Cardiovasc. Med., 3: 41-57, 1978.
14.
Miller, R.R. , Awan, N.A., Maxwell , K.S., et al.: Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin. N. Engl. J. Med. , 297: 303-307, 1977.
15.
Aldactone (spironolactone), in Physician's Desk Reference. Thrity-second edition. Oradell, NJ: Medical Economics , 1978, p. 1537.
16.
Ayers, C.R., Slaughter, A.R., Smallwood, A.D., et al.: Standards for the quality care of hypertensive patients in office and hospital practice, in Hypertension Manual. Edited by J. H. Laragh.New York, Yorke Medical Books, 1974, p. 699.
17.
Antihypertensive agents, in AMA Drug Evaluations . First edition. Chicago, American Medical Association, 1971, p. 31.
18.
Status report on beta-blockers, in FDA Drug Bull., 8: 13, 1978.
19.
Stokes, G.S. , Gain, J.M., Mahony , J.F., et al.: Long-term use of prazosin in combination or alone for treating hypertension. Med. J. Aust., 2: 13-16, 1977 (suppl.).
20.
Simpson, F.O. , Bolli, P., Wood , A.J.: Use of prazosin at the Dunedin hypertension clinic. Med. J. Aust., 2: 17-22, 1977 (suppl.).
21.
Marshall, A.J. , Pocock, J., Barritt , D.W., et al.: Evaluation of beta blockade, bendrofluazide, and prazosin in severe hypertension. Lancet, 1: 271-275, 1977.
22.
Buhler, F.R. , Bertel, O., Lutold , B.E.: Simplified and age-stratified antihypertensive therapy based on beta blockers. Cardiovasc. Med., 3: 135, 1978.
23.
Castelli, W.P. : CHD risk factors in the elderly. Hosp. Practice, 11: 113-121, 1976.